These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1515568)

  • 1. The interferon-alpha 2b gene in Japanese patients with chronic viral hepatitis who developed antibodies after treatment with recombinant interferon-alpha 2a.
    Hosoi H; Imai M; Yamanaka M
    J Gastroenterol Hepatol; 1992; 7(4):411-6. PubMed ID: 1515568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon (IFN)-alpha 2 genotype analysis of Chinese chronic hepatitis B patients undergoing recombinant IFN-alpha 2a therapy.
    Crowe JS; Gewert DR; Barber KA; Lewis AP; Sims MJ; Davies SL; Salom CL; Wood J; Thomas HC; Thursz M
    J Infect Dis; 1994 Apr; 169(4):875-8. PubMed ID: 8133104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally occurring anti-interferon-alpha 2a antibodies in patients with acute viral hepatitis.
    Ikeda Y; Toda G; Hashimoto N; Umeda N; Miyake K; Yamanaka M; Kurokowa K
    Clin Exp Immunol; 1991 Jul; 85(1):80-4. PubMed ID: 1906385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of interferon-alpha expression by PCR in patients with chronic hepatitis C and hepatitis non-A, non-B.
    Brandt ER; Devenish RJ; Hertzog PJ; Dudley FJ; Linnane AW
    J Gastroenterol Hepatol; 1994; 9(4):373-80. PubMed ID: 7948820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the presence of serum autoantibodies influence the responsiveness to interferon-alpha 2a treatment in chronic hepatitis C?
    Wada M; Kang KB; Kinugasa A; Shintani S; Sawada K; Nishigami T; Shimoyama T
    Intern Med; 1997 Apr; 36(4):248-54. PubMed ID: 9187562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
    Chung YH; Shong YK
    Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-interferon antibody in chronic hepatitis C].
    Arai K; Shindo M; Okuno T
    Nihon Rinsho; 1994 Jul; 52(7):1929-34. PubMed ID: 7521441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alpha 2b but not interferon alpha 2a detected in human genomic DNA.
    Kaluz S; Gibadulinová A; Kontsek P
    Acta Virol; 1993 Feb; 37(1):97-100. PubMed ID: 8105656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon immunogenicity: preclinical evaluation of interferon-alpha 2a.
    Palleroni AV; Aglione A; Labow M; Brunda MJ; Pestka S; Sinigaglia F; Garotta G; Alsenz J; Braun A
    J Interferon Cytokine Res; 1997 Jul; 17 Suppl 1():S23-7. PubMed ID: 9241612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha neutralizing antibodies in HIV and chronic HCV patients treated with natural-source human leukocyte-derived interferon-alpha n3.
    Zhao XX; Hua J; Smith T; Ferencz-Biro K; Liao MJ; Rashidbaigi A
    Hum Antibodies; 1997; 8(3):129-36. PubMed ID: 9322083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of anti-interferon-alpha 2a antibodies in chronic liver disease.
    Ikeda Y; Miyake K; Toda G; Yamada H; Yamanaka M; Oka H
    J Gastroenterol Hepatol; 1989; 4(5):411-8. PubMed ID: 2491207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of interferon-alpha 2 sequences in human genomic DNA.
    Gewert D; Salom C; Barber K; Macbride S; Cooper H; Lewis A; Wood J; Crowe S
    J Interferon Res; 1993 Jun; 13(3):227-31. PubMed ID: 8366289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of peginterferon alfa-2a and alfa-2b for treatment of patients with chronic hepatitis C: a retrospective study using the Japanese Interferon Database.
    Sato I; Shimbo T; Kawasaki Y; Masaki N
    Drug Des Devel Ther; 2015; 9():283-90. PubMed ID: 25565777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations.
    Antonelli G; Currenti M; Turriziani O; Dianzani F
    J Infect Dis; 1991 Apr; 163(4):882-5. PubMed ID: 1901335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing anti-interferon-alpha antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (alpha 2a) and lymphoblastoid interferon-alpha.
    Russo D; Candoni A; Zuffa E; Minisini R; Silvestri F; Fanin R; Zaja F; Martinelli G; Tura S; Botta G; Baccarani M
    Br J Haematol; 1996 Aug; 94(2):300-5. PubMed ID: 8759890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of anti-interferon-alpha 2a antibodies in initial daily four-week interferon-alpha 2a therapy for chronic hepatitis C].
    Habu D; Mizuno M; Ohnishi K; Watanabe A; Son J; Iwano M; Murakoshi R; Takino T; Mizuma Y; Kobayashi M
    Nihon Shokakibyo Gakkai Zasshi; 1997 May; 94(5):319-27. PubMed ID: 9170879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 48 weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection.
    Hui CK; Lai LS; Lam P; Zhang HY; Fung TT; Lai ST; Wong WM; Lo CM; Fan ST; Leung N; Lau GK;
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1171-8. PubMed ID: 16611278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet antibodies in patients with chronic viral hepatitis receiving interferon-alpha.
    Christodoulou D; Christou L; Zervou E; Katsanos K; Kitsanou M; Tsianos EV
    Hepatogastroenterology; 2007 Sep; 54(78):1761-5. PubMed ID: 18019713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection.
    Milella M; Antonelli G; Santantonio T; Currenti M; Monno L; Mariano N; Angarano G; Dianzani F; Pastore G
    Liver; 1993 Jun; 13(3):146-50. PubMed ID: 8336526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.
    Tassopoulos NC; Koutelou MG; Papatheodoridis G; Polychronaki H; Delladetsima I; Giannikakis T; Todoulos A; Toliopoulos A; Hatzakis A
    Gut; 1993; 34(2 Suppl):S130-2. PubMed ID: 7686113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.